Shaanxi Meibang makes huge decline in H1 revenue

On 29 Aug., 2023, Shaanxi Meibang Pharmaceutical Group Co., Ltd. (Shaanxi Meibang) unveiled the semi-annual report for 2023, in which the company's revenue decreased 22.91% YoY to USD66.33 million (RMB476.15 million), mainly owing to significant slid...

Fungicides China Monthly Report 202309

www.cnchemicals.com